SEC Form 4 · accession 0001127602-17-020275
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark E Tryniski
Director
Period of report
Jun 1, 2017
Accepted (ET)
Jun 2, 2017 · 3:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2017 | M | 3,653 | $0.00 | A | 31,678 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rsus (restricted Stock Units)F1 | $0.00 | Jun 1, 2017 | M | 3,653 | D | Jun 1, 2017 | Jun 1, 2026 | Common Stock | 3,653 | 0 | D |
| Rsus (restricted Stock Units)F1 | $0.00 | Jun 1, 2017 | A | 2,890 | A | Jun 1, 2018 | Jun 1, 2027 | Common Stock | 2,890 | 2,890 | D |
| Options To Purchase Common StockF2 | $51.90 | Jun 1, 2017 | A | 4,892 | A | Jun 1, 2018 | Jun 1, 2027 | Common Stock | 4,892 | 4,892 | D |
Explanation of responses
- F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
- F2The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.